Inactive Instrument
Kadimastem Stock TEL AVIV STOCK EXCHANGE
Stocks
KDST
IL0011284614
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 50.75M 14.8B 43.88M 40.42M 37.86M 70.98M 4.83B 72.06M 479M 186M 2.35B 190M 186M 8.13B | P/E Ratio 2024 * |
-
| P/E Ratio 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 48.9M 14.26B 42.28M 38.95M 36.48M 68.4M 4.65B 69.44M 462M 179M 2.26B 184M 180M 7.83B | EV / Sales 2024 * |
-
| EV / Sales 2025 | - |
| Free-Float |
35.62% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.93% | - | - | 17.58M | |
| -0.35% | -0.22% | -15.03% | -12.88% | 42.96B | |
| +3.11% | -1.17% | +277.22% | +502.47% | 31.73B | |
| +0.22% | -2.90% | +14.25% | -12.16% | 30.22B | |
| +1.62% | -5.52% | +0.79% | +22.42% | 28.94B | |
| +4.09% | -1.98% | +11.99% | +17.37% | 23.87B | |
| -1.63% | +1.89% | +54.59% | +124.83% | 13.57B | |
| -0.40% | -1.48% | +7.48% | +7.12% | 12.96B | |
| +1.14% | -0.36% | - | - | 13.39B | |
| -0.74% | -2.47% | +102.47% | +80.26% | 12.2B | |
| Average | +0.30% | -0.71% | +56.72% | +91.18% | 23.31B | |
| Weighted average by Cap. | +0.40% | -1.08% | +55.88% | +95.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.55M -7.74B -22.96M -21.15M -19.81M -37.14M -2.53B -37.7M -251M -97.34M -1.23B -99.64M -97.52M -4.25B | -8.3M -2.42B -7.18M -6.61M -6.19M -11.61M -789M -11.78M -78.33M -30.43M -384M -31.15M -30.48M -1.33B |
| Net Debt | 7.35M 2.14B 6.35M 5.85M 5.48M 10.28M 699M 10.43M 69.33M 26.94M 340M 27.57M 26.98M 1.18B | -1.85M -538M -1.6M -1.47M -1.38M -2.58M -176M -2.62M -17.42M -6.77M -85.4M -6.93M -6.78M -296M |
Employees
11
